ArticleRMD open2021

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD.

Anne Constanze Regierer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.